Senior Associate Consultant and Assistant Professor, Mayo Clinic
BIOGRAPHY
Speaker
Event Date & Time
Date: June 18, 2024
Time: 8:00 AM (PDT), 11:00 AM (EDT), 5:00 PM (CEST)
Abstract
Patients with rheumatoid arthritis (RA) can be categorized as either anti-citrullinated protein antibody-positive (ACPA+) or negative (ACPA-). In this webinar, Dr. Sung will present his research exploring a broad range of serological autoantibodies to uncover immunological differences between these RA subgroups using data from ACPA+ RA patients, ACPA- RA patients, and matched healthy controls.
Learning Objectives:
- Learn how 1600+ IgG autoantibodies from serum were screened, yielding biologically relevant and immunologically significant insights.
- Discover the distinct autoantibody profiles identified in ACPA+ and ACPA- patients.
- Understand which proteins and their associated biological processes were predominantly targeted by these autoantibodies.
- Explore the implications of autoantibody biomarkers in RA subgroups and their correlation with the Clinical Disease Activity Index, a measure of disease activity.
- Examine how autoantibody biomarker signatures can enhance patient stratification and diagnostic accuracy in RA.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...